Carl J Pepine

Carl J Pepine, M.D.

Professor Of Medicine

Department: MD-CARDIOLOGY
Business Phone: (352) 273-9082
Business Email: pepincj@medicine.ufl.edu

About Carl J Pepine

Carl J. Pepine, MD, is a doctor in the Division of Cardiovascular Medicine at the University of Florida College of Medicine. He graduated from the University of Pittsburgh in 1962 with his bachelor’s degree.

As he started medical school at Rutgers in New Jersey with his MD in 1966, Pepine stayed in the northeast for his internship at Allegheny General Hospital, a University of Pittsburgh affiliate. His two residencies were at Jefferson Medical College Hospital and Regional Naval Medical Center. He completed both fellowships in 1971 and became board certified in Internal Medicine and the subspeciality of Cardiovascular Disease.

He is currently a principal investigator of many NIH- and industry-funded research projects on cardiovascular disease in women, IHD, hypertension, heart failure, and cell-based therapy, with continuous peer-reviewed federal research funding (DoD, NIH, VA Merit) for over 40 years.

Pepine served as Chief of the UF Division of Cardiovascular Medicine from 1998–2008 and Chief of Cardiology, VA Medical Center, from 1978–1994. He has published more than 1,100 scientific articles, has edited 6 textbooks, and has been on the editorial boards of all major cardiovascular journals. He is the founding editor of Cardiology Today and Editor-in-Chief for American Heart Journal Plus: Cardiology Research and Practice. Pepine is currently the co-director of CTSI Multi-site Study Support Team at the National Center for Research.

Accomplishments

Wenger Award for Excellence in Medical research and Leadership
2019 · National Coalition for Women with Heart Disease
Bernadine Healy Leadership in Women’s Cardiovascular Disease Award
2018 · American College of Cardiology
Lifetime Achievement Award
2010 · University of Florida
Gifted Scientist Award
2009 · Florida Chapter, American College of Cardiology
Distinguished International Educator
2005 · University of Florida
President
2003-2004 · American College of Cardiology
Eminent Scholar Chair in Cardiovascular Research (UF)
2001-2008 · American Heart Association (AHA) – Suncoast Chapter, Inc.
Gifted Teacher Award
2001 · Florida Chapter, American College of Cardiology
Research Foundation Professorship Award
1999-2001 · University of Florida
Elected to Association of University Cardiologists (AUC)
1998 · Association of University Cardiologists
Theodore E. Woodward Award
1998 · American Clinical and Climatological Association (ACCA)
Paul Dudley White Award
1991 · Association of Military Surgeons of the United States
President
1986-1987 · Florida Chapter, Amercian College of Cardiology
Elected to the American Society for Clinical Investigation (ASCI)
1982 · American Society for Clinical Investigation
Outstanding Young Men of America
1972 · Outstanding Young Men of America

Teaching Profile

Courses Taught
2014
GMS6335 Tissue Engineering

Board Certifications

  • Cardiovascular Disease
    American Board of Internal Medicine
  • Diplomate
    American Board of Internal Medicine
  • Diplomate
    National Board of Medical Examiners

Clinical Profile

Specialties
  • Cardiology
Areas of Interest
  • Cardiomyopathy
  • Coronary heart disease
  • Essential hypertension

Research Profile

My career has focused on improving our understanding of mechanisms underlying ischemic heart disease (IHD) and related adverse outcomes. I have conducted extensive investigations in coronary artery disease (CAD), hypertension, treatment resistant hypertension, vascular biology, and therapeutic applications related to vascular dysfunction. My work has centered on how IHD becomes manifest with and without large coronary artery obstructive disease (CAD). Much of this work is concentrated in women with known or suspect IHD. A major goal of clinical research is development of actionable information of sufficient power to alter medical care and improve patient health by information obtained through performance of clinical trials. To this end, I conceived and led the first randomized controlled international mega-trial of blood pressure control for patients with CAD (INVEST). My experience also includes being a principal investigator (PI) in multiple NHLBI-funded projects [Women’s Ischemia Syndrome Evaluation (WISE), WISE-CVD, WISE HFpEF, MayWEST, Asymptomatic Cardiac Ischemia Pilot (ACIP), Psychophysiologic Interventions of Myocardial Ischemia (PIMI), Bypass Angioplasty Revascularization Investigation 2-Diabetes Trial (BARI2D), etc.] and many other industry-sponsored studies. More recently I have been working in cardiovascular recovery and regeneration with cell based therapies as a PI in the NHLBI Cardiovascular Cell Therapy Network (CCTRN)- 1 and 2, as well as studies funded by the the cell and gene biomedical industry.

Open Researcher and Contributor ID (ORCID)

0000-0002-6011-681X

Areas of Interest
  • Cardiovascular Cell Therapy
  • Heart Disease in Women
  • Heart Failure
  • Hypertension
  • Ischemic Heart Disease

Publications

Academic Articles
2024
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.
Circulation. Cardiovascular interventions. 17(5) [DOI] 10.1161/CIRCINTERVENTIONS.124.014054. [PMID] 38696284.
2024
Arterial stiffness assessment in coronary microvascular dysfunction and heart failure with preserved ejection fraction: An initial report from the WISE-CVD continuation study.
American heart journal plus : cardiology research and practice. 41 [DOI] 10.1016/j.ahjo.2024.100390. [PMID] 38600957.
2024
Comparison of risk profiles of participants in the Women’s IschemiA TRial to Reduce events In non-ObstRuctive CAD (WARRIOR) trial, using Coronary Computed Tomography Angiography vs Invasive Coronary Angiography.
Progress in cardiovascular diseases. 84:90-93 [DOI] 10.1016/j.pcad.2024.03.008. [PMID] 38547955.
2024
Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) Study.
American heart journal. 278:41-47 [DOI] 10.1016/j.ahj.2024.08.021. [PMID] 39233211.
2024
Elevated high-density lipoprotein cholesterol and adverse outcomes in women with symptoms of ischemic heart disease.
American heart journal plus : cardiology research and practice. 40 [DOI] 10.1016/j.ahjo.2024.100376. [PMID] 38510502.
2024
Endogenous androgens, coronary atheroma and remodeling in women with suspected ischemic heart disease: A report from the Women’s Ischemia Syndrome Evaluation (WISE) study.
American heart journal plus : cardiology research and practice. 43 [DOI] 10.1016/j.ahjo.2024.100411. [PMID] 38873103.
2024
Evaluation of coronary microvascular dysfunction using magnetocardiography: A new application to an old technology.
American heart journal plus : cardiology research and practice. 44 [DOI] 10.1016/j.ahjo.2024.100424. [PMID] 39108843.
2024
Hospitalization after hydroxychloroquine initiation in patients with heart failure with preserved ejection fraction and autoimmune disease.
Journal of internal medicine. 296(5):399-409 [DOI] 10.1111/joim.20004. [PMID] 39193799.
2024
Identifying Potential Factors Associated With Racial Disparities in COVID-19 Outcomes: Retrospective Cohort Study Using Machine Learning on Real-World Data.
JMIR public health and surveillance. 10 [DOI] 10.2196/54421. [PMID] 39326040.
2024
Impact of epicardial fat on coronary vascular function, cardiac morphology, and cardiac function in women with suspected INOCA.
European heart journal. Cardiovascular Imaging. 25(10):1360-1366 [DOI] 10.1093/ehjci/jeae203. [PMID] 39129200.
2024
Initial Antihypertensive Prescribing in Relation to Blood Pressure Among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium.
Hypertension (Dallas, Tex. : 1979). 81(2):e7-e9 [DOI] 10.1161/HYPERTENSIONAHA.123.21901. [PMID] 38232142.
2024
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines.
European heart journal. 45(36):3701-3706 [DOI] 10.1093/eurheartj/ehae278. [PMID] 39211956.
2024
Myocardial Ischemic Syndromes: A New Nomenclature to Harmonize Evolving International Clinical Practice Guidelines.
Circulation. 150(20):1631-1637 [DOI] 10.1161/CIRCULATIONAHA.123.065656. [PMID] 39210827.
2024
Pericardial fat volume is related to endothelial-mediated coronary blood flow in women with suspected coronary microvascular dysfunction. A report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
American heart journal plus : cardiology research and practice. 40 [DOI] 10.1016/j.ahjo.2024.100379. [PMID] 38586431.
2024
Physiology and functional significance of the coronary microcirculation: An overview of its implications in health and disease.
American heart journal plus : cardiology research and practice. 40 [DOI] 10.1016/j.ahjo.2024.100381. [PMID] 38586427.
2024
Racial/ethnic disparities, artificial intelligence, and cutting-edge research: Proceedings from the 2023 Florida cardio-oncology symposium.
American heart journal plus : cardiology research and practice. 46 [DOI] 10.1016/j.ahjo.2024.100469. [PMID] 39431118.
2024
Recipe for Heart Health: A Randomized Crossover Trial on Cardiometabolic Effects of Extra Virgin Olive Oil Within a Whole-Food Plant-Based Vegan Diet.
Journal of the American Heart Association. 13(15) [DOI] 10.1161/JAHA.124.035034. [PMID] 39045758.
2024
Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction.
Journal of the American Heart Association. 13(4) [DOI] 10.1161/JAHA.123.032137. [PMID] 38348798.
2024
Towards real-time myocardial infarction diagnosis: a convergence of machine learning and ion-exchange membrane technologies leveraging miRNA signatures.
Lab on a chip. 24(23):5203-5214 [DOI] 10.1039/d4lc00640b. [PMID] 39415669.
2023
An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
International journal of cardiology. 373:17-22 [DOI] 10.1016/j.ijcard.2022.11.036. [PMID] 36442672.
2023
ANOCA/INOCA/MINOCA: Open artery ischemia.
American heart journal plus : cardiology research and practice. 26 [DOI] 10.1016/j.ahjo.2023.100260. [PMID] 37064505.
2023
Association of abnormal electrocardiography response on dobutamine stress echocardiogram with longer-term major adverse cardiovascular events in women with symptoms of ischemic heart disease.
Cardiovascular diagnosis and therapy. 13(6):948-955 [DOI] 10.21037/cdt-23-296. [PMID] 38162097.
2023
Association of Coronary Artery Dominance With Long-term Outcomes in Female Patients With Suspected Ischemia but Nonobstructive Coronary Artery Disease.
Journal of the Society for Cardiovascular Angiography & Interventions. 2(5) [DOI] 10.1016/j.jscai.2023.101064. [PMID] 39132402.
2023
Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) project.
Frontiers in cardiovascular medicine. 10 [DOI] 10.3389/fcvm.2023.1155914. [PMID] 37324629.
2023
Chronic rheumatologic disorders and cardiovascular disease risk in women.
American heart journal plus : cardiology research and practice. 27 [DOI] 10.1016/j.ahjo.2023.100267. [PMID] 38511090.
2023
Circulating Biomarkers in Coronary Microvascular Dysfunction.
Journal of the American Heart Association. 12(12) [DOI] 10.1161/JAHA.122.029341. [PMID] 37301749.
2023
Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial.
BMC infectious diseases. 23(1) [DOI] 10.1186/s12879-023-08295-9. [PMID] 37189091.
2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE.
American heart journal. 264:31-39 [DOI] 10.1016/j.ahj.2023.06.001. [PMID] 37290700.
2023
Dietary Composition, Angiographic Coronary Disease, and Cardiovascular Outcomes in the WISE Study (Women’s Ischemia Syndrome Evaluation).
Journal of clinical medicine. 12(24) [DOI] 10.3390/jcm12247762. [PMID] 38137831.
2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial.
JAMA cardiology. 8(11):1061-1069 [DOI] 10.1001/jamacardio.2023.3364. [PMID] 37792369.
2023
Evolving Management Paradigm for Stable Ischemic Heart Disease Patients: JACC Review Topic of the Week.
Journal of the American College of Cardiology. 81(5):505-514 [DOI] 10.1016/j.jacc.2022.08.814. [PMID] 36725179.
2023
EXACT Trial: Results of the Phase 1 Dose-Escalation Study.
Circulation. Cardiovascular interventions. 16(8) [DOI] 10.1161/CIRCINTERVENTIONS.123.012997. [PMID] 37503661.
2023
Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome.
American journal of preventive cardiology. 14 [DOI] 10.1016/j.ajpc.2023.100498. [PMID] 37181803.
2023
Heart and brain interactions: is small vessel disease a link?
European heart journal. 44(2):126-128 [DOI] 10.1093/eurheartj/ehac570. [PMID] 36367735.
2023
High-throughput screening for prescribing cascades among real world statin initiators.
Pharmacoepidemiology and drug safety. 32(7):773-782 [DOI] 10.1002/pds.5607. [PMID] 36880251.
2023
Host-Microbiota Communication in Spontaneously Hypertensive Rats Generates Unique IgA-Coated Gut Microbes.
Journal of the American Heart Association. 12(4) [DOI] 10.1161/JAHA.122.027918. [PMID] 36752270.
2023
Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure.
International journal of molecular sciences. 24(3) [DOI] 10.3390/ijms24032650. [PMID] 36768972.
2023
Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Journal of the American Heart Association. 12(1) [DOI] 10.1161/JAHA.122.026652. [PMID] 36565195.
2023
Latest from the WISE: Contributions to the Understanding of Ischemia and Heart Failure among Women with No Obstructive Coronary Arteries.
Reviews in cardiovascular medicine. 24(3) [DOI] 10.31083/j.rcm2403090. [PMID] 39077501.
2023
Left ventricular ejection fraction and long-term outcomes in women presenting with signs and symptoms of ischaemia.
Heart (British Cardiac Society). 109(21):1624-1630 [DOI] 10.1136/heartjnl-2023-322494. [PMID] 37316162.
2023
Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women’s Ischemia Syndrome Evaluation) Cohort.
Circulation. 147(7):617-619 [DOI] 10.1161/CIRCULATIONAHA.122.063466. [PMID] 36780383.
2023
Long-term Adverse Outcomes in Black Women With Obstructive Coronary Artery Disease: A Study of the Women’s Ischemia Syndrome Evaluation (WISE) Cohort.
The Canadian journal of cardiology. 39(11):1664-1666 [DOI] 10.1016/j.cjca.2023.08.010. [PMID] 37897475.
2023
Longitudinal cardiac remodeling in collegiate American football players as assessed by echocardiography during their collegiate career.
Clinical cardiology. 46(9):1090-1096 [DOI] 10.1002/clc.24121. [PMID] 37573574.
2023
Modifiable statin characteristics associated with potential statin-related prescribing cascades.
Pharmacotherapy. 43(12):1307-1316 [DOI] 10.1002/phar.2883. [PMID] 37771303.
2023
Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy.
Journal of the American Heart Association. 12(10) [DOI] 10.1161/JAHA.122.027981. [PMID] 37158063.
2023
Relationship between arm span to height ratio, aortic root diameter, and systolic blood pressure in collegiate athletes.
American heart journal plus : cardiology research and practice. 25 [DOI] 10.1016/j.ahjo.2022.100242. [PMID] 38510494.
2023
Reprograming of transcriptional profile of colonic organoids from patients with high blood pressure by minocycline.
American heart journal plus : cardiology research and practice. 36 [DOI] 10.1016/j.ahjo.2023.100343. [PMID] 38222308.
2023
Sex-Specific Effects of Blood Pressure Lowering Pharmacotherapy for the Prevention of Cardiovascular Disease: An Individual Participant-Level Data Meta-Analysis.
Hypertension (Dallas, Tex. : 1979). 80(11):2293-2302 [DOI] 10.1161/HYPERTENSIONAHA.123.21496. [PMID] 37485657.
2023
Social Vulnerability Is Associated With Higher Rates of Hospitalizations and Amputations for Peripheral Arterial Disease.
The American journal of cardiology. 203:463-465 [DOI] 10.1016/j.amjcard.2023.07.063. [PMID] 37542956.
2023
Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA).
Journal of clinical medicine. 12(18) [DOI] 10.3390/jcm12185836. [PMID] 37762777.
2023
The CardiAMP Cell Therapy for Heart Failure trial.
Texas Heart Institute journal. 50(5) [DOI] 10.14503/THIJ-23-8242. [PMID] 37881037.
2022
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis.
Frontiers in physiology. 13 [DOI] 10.3389/fphys.2022.909870. [PMID] 35812313.
2022
Blood pressure characteristics of collegiate female athletes: A call for more focused attention on young women’s health.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2022.100085. [PMID] 38560086.
2022
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
The lancet. Diabetes & endocrinology. 10(9):645-654 [DOI] 10.1016/S2213-8587(22)00172-3. [PMID] 35878651.
2022
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women?
European journal of preventive cardiology. 29(12):1608-1614 [DOI] 10.1093/eurjpc/zwac046. [PMID] 35244151.
2022
Cold Pressor Testing and Sympathetic Nervous System Contribution to Ischemia with No Obstructive Coronary Artery Disease: Results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Project.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2021.100080. [PMID] 36262746.
2022
Concomitant coronary microvascular dysfunction and spontaneous coronary artery dissection resulting in ST-segment elevation myocardial infarction.
Journal of cardiology cases. 25(2):76-78 [DOI] 10.1016/j.jccase.2021.06.014. [PMID] 35079302.
2022
Coronary microvascular dysfunction as a chronic inflammatory state: Is there a role for omega-3 fatty acid treatment?
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2022.100098. [PMID] 38560085.
2022
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions.
Drugs. 82(3):241-250 [DOI] 10.1007/s40265-021-01667-y. [PMID] 35092594.
2022
Critical role of the coronary microvasculature in heart disease: From pathologic driving force to “innocent” bystander.
American heart journal plus : cardiology research and practice. 22 [DOI] 10.1016/j.ahjo.2022.100215. [PMID] 38558907.
2022
Dare to dream? Cell-based therapies for heart failure after DREAM-HF: Review and roadmap for future clinical study.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2022.100118. [PMID] 38560073.
2022
Depression Symptom Patterns as Predictors of Metabolic Syndrome and Cardiac Events in Symptomatic Women with Suspected Myocardial Ischemia: The Women’s Ischemia Syndrome Evaluation (WISE and WISE-CVD) Projects.
Heart and mind (Mumbai, India). 6(4):254-261 [PMID] 36994354.
2022
Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials.
International journal of cardiology. 359:46-53 [DOI] 10.1016/j.ijcard.2022.04.039. [PMID] 35436558.
2022
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis.
Stem cells translational medicine. 11(7):688-703 [DOI] 10.1093/stcltm/szac032. [PMID] 35640138.
2022
Evaluation of a Beta-Blocker-Edema-Loop Diuretic Prescribing Cascade: A Prescription Sequence Symmetry Analysis.
American journal of hypertension. 35(7):601-609 [DOI] 10.1093/ajh/hpac013. [PMID] 35106529.
2022
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade.
Pharmacoepidemiology and drug safety. 31(1):72-81 [DOI] 10.1002/pds.5362. [PMID] 34553438.
2022
First and recurrent events in the ISCHEMIA trial: two sides of the same coin.
European heart journal. 43(2):150-152 [DOI] 10.1093/eurheartj/ehab603. [PMID] 34514507.
2022
Gut Microbiome and Neuroinflammation in Hypertension.
Circulation research. 130(3):401-417 [DOI] 10.1161/CIRCRESAHA.121.319816. [PMID] 35113664.
2022
Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors.
Hypertension (Dallas, Tex. : 1979). 79(8):1591-1601 [DOI] 10.1161/HYPERTENSIONAHA.121.18711. [PMID] 35538603.
2022
Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recipient: Rationale and design of the uSTOP LVAD BLEED pilot study.
American heart journal plus : cardiology research and practice. 16 [DOI] 10.1016/j.ahjo.2022.100142. [PMID] 38559284.
2022
Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
International journal of cardiology. 348:1-8 [DOI] 10.1016/j.ijcard.2021.12.013. [PMID] 34902504.
2022
Ischemic Heart Disease in Young Women: JACC Review Topic of the Week.
Journal of the American College of Cardiology. 80(10):1014-1022 [DOI] 10.1016/j.jacc.2022.01.057. [PMID] 36049799.
2022
Medicare Bundled Payment Policy on Anemia Care, Major Adverse Cardiovascular Events, and Mortality among Adults Undergoing Hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN. 17(6):851-860 [DOI] 10.2215/CJN.14361121. [PMID] 35589388.
2022
Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence
The American journal of medicine. 135(9):1059-1068 [DOI] 10.1016/j.amjmed.2022.04.006. [PMID] 35472396.
2022
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned.
Current atherosclerosis reports. 24(9):681-687 [DOI] 10.1007/s11883-022-01044-4. [PMID] 35781776.
2022
Our academic heritage from CR Conti-A lifetime committed to education and excellence.
Clinical cardiology. 45(11):1085-1088 [DOI] 10.1002/clc.23912. [PMID] 36165103.
2022
Prognostic association of plasma NT-proBNP levels in patients with microvascular angina -A report from the international cohort study by COVADIS.
International journal of cardiology. Heart & vasculature. 43 [DOI] 10.1016/j.ijcha.2022.101139. [PMID] 36338319.
2022
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use.
Cardiovascular research. 118(11):2428-2436 [DOI] 10.1093/cvr/cvab270. [PMID] 34387303.
2022
Relationship of Psychological Characteristics to Daily Life Ischemia: An Analysis From the National Heart, Lung, and Blood Institute Psychophysiological Investigations in Myocardial Ischemia.
Psychosomatic medicine. 84(3):359-367 [DOI] 10.1097/PSY.0000000000001044. [PMID] 35067655.
2022
RNA Virus Gene Signatures Detected in Patients With Cardiomyopathy After Chemotherapy; A Pilot Study.
Frontiers in cardiovascular medicine. 9 [DOI] 10.3389/fcvm.2022.821162. [PMID] 35360008.
2022
Sex-dimorphic gene effects on survival outcomes in people with coronary artery disease.
American heart journal plus : cardiology research and practice. 17 [DOI] 10.1016/j.ahjo.2022.100152. [PMID] 35959094.
2022
Specialized Proresolving Mediators in Symptomatic Women With Coronary Microvascular Dysfunction (from the Women’s Ischemia Trial to Reduce Events in Nonobstructive CAD [WARRIOR] Trial).
The American journal of cardiology. 162:1-5 [DOI] 10.1016/j.amjcard.2021.09.015. [PMID] 34728061.
2022
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports.
Journal of hypertension. 40(5):847-852 [DOI] 10.1097/HJH.0000000000003107. [PMID] 35221323.
2022
Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction.
American heart journal plus : cardiology research and practice. 22 [DOI] 10.1016/j.ahjo.2022.100213. [PMID] 37377675.
2022
Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease.
American heart journal plus : cardiology research and practice. 13 [DOI] 10.1016/j.ahjo.2022.100115. [PMID] 35784010.
2022
What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?
Cardiovascular drugs and therapy. 36(5):1027-1038 [DOI] 10.1007/s10557-021-07179-x. [PMID] 33978865.
2021
A multiplexed ion-exchange membrane-based miRNA (MIX·miR) detection platform for rapid diagnosis of myocardial infarction.
Lab on a chip. 21(20):3876-3887 [DOI] 10.1039/d1lc00685a. [PMID] 34546237.
2021
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
European journal of heart failure. 23(4):661-674 [DOI] 10.1002/ejhf.2178. [PMID] 33811444.
2021
A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study.
Nutrients. 13(10) [DOI] 10.3390/nu13103459. [PMID] 34684459.
2021
Acute Pulmonary Embolism During Pregnancy and Puerperium: National Trends and In-Hospital Outcomes.
Mayo Clinic proceedings. 96(8):2102-2113 [DOI] 10.1016/j.mayocp.2021.01.015. [PMID] 34144802.
2021
Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.
Clinical pharmacology and therapeutics. 110(3):723-732 [DOI] 10.1002/cpt.2355. [PMID] 34231218.
2021
Anemia and Long-term cardiovascular outcomes in women with suspected ischemia – The Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal plus : cardiology research and practice. 10 [DOI] 10.1016/j.ahjo.2021.100059. [PMID] 38550401.
2021
Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
International journal of cardiology. 333:35-39 [DOI] 10.1016/j.ijcard.2021.02.064. [PMID] 33662486.
2021
Antihypertensive medication adherence trends by sex and drug class: A pilot study.
American heart journal plus : cardiology research and practice. 5 [DOI] 10.1016/j.ahjo.2021.100023. [PMID] 38560412.
2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
The Lancet. Oncology. 22(4):558-570 [DOI] 10.1016/S1470-2045(21)00033-4. [PMID] 33794209.
2021
Aspirin in Primary Prevention: What Changed? A Critical Appraisal of Current Evidence.
The American journal of cardiology. 141:38-48 [DOI] 10.1016/j.amjcard.2020.11.014. [PMID] 33221264.
2021
Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
JAMA network open. 4(4) [DOI] 10.1001/jamanetworkopen.2021.8418. [PMID] 33914047.
2021
Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
Clinical cardiology. 44(11):1586-1593 [DOI] 10.1002/clc.23726. [PMID] 34528718.
2021
Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Lancet (London, England). 398(10313):1803-1810 [DOI] 10.1016/S0140-6736(21)01920-6. [PMID] 34774144.
2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
PLoS medicine. 18(6) [DOI] 10.1371/journal.pmed.1003599. [PMID] 34061831.
2021
Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.
Hypertension (Dallas, Tex. : 1979). 77(2):e13-e16 [DOI] 10.1161/HYPERTENSIONAHA.120.16647. [PMID] 33439735.
2021
Cardiac Sympathetic Activity by 123I-Meta-Iodobenzylguanidine Imaging in Women With Coronary Microvascular Dysfunction: A Pilot Study.
JACC. Cardiovascular imaging. 14(9):1873-1875 [DOI] 10.1016/j.jcmg.2021.03.031. [PMID] 34147436.
2021
Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group.
European heart journal. 42(44):4592-4600 [DOI] 10.1093/eurheartj/ehab282. [PMID] 34038937.
2021
Clinical Safety Profile of Transendocardial Catheter Injection Systems: A Plea for Uniform Reporting.
Cardiovascular revascularization medicine : including molecular interventions. 22:100-108 [DOI] 10.1016/j.carrev.2020.06.031. [PMID] 32651159.
2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trial.
Clinical trials (London, England). 18(4):449-456 [DOI] 10.1177/1740774520988838. [PMID] 33541120.
2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
The New England journal of medicine. 384(21):1981-1990 [DOI] 10.1056/NEJMoa2102137. [PMID] 33999548.
2021
Coronary atheroma burden predicts flow reserve in women with ischemia and nonobstructive coronary artery disease.
American heart journal plus : cardiology research and practice. 6 [DOI] 10.1016/j.ahjo.2021.100027. [PMID] 38560556.
2021
Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study.
PloS one. 16(9) [DOI] 10.1371/journal.pone.0257184. [PMID] 34570768.
2021
Depression phenotype identified by using single nucleotide exact amplicon sequence variants of the human gut microbiome.
Molecular psychiatry. 26(8):4277-4287 [DOI] 10.1038/s41380-020-0652-5. [PMID] 31988436.
2021
Depressive hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
American heart journal. 239:27-37 [DOI] 10.1016/j.ahj.2021.05.002. [PMID] 33984318.
2021
Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5.
Journal of the American College of Cardiology. 77(14):1813-1822 [DOI] 10.1016/j.jacc.2021.01.056. [PMID] 33832607.
2021
Distinct Gene Expression Profiles in Colonic Organoids from Normotensive and the Spontaneously Hypertensive Rats.
Cells. 10(6) [DOI] 10.3390/cells10061523. [PMID] 34204247.
2021
Does Patient-Physician Gender Concordance Influence Patient Perceptions or Outcomes?
Journal of the American College of Cardiology. 77(8):1135-1138 [DOI] 10.1016/j.jacc.2020.12.031. [PMID] 33632488.
2021
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial.
JAMA. 326(17):1703-1712 [DOI] 10.1001/jama.2021.17272. [PMID] 34633405.
2021
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study.
Pharmacotherapy. 41(9):710-721 [DOI] 10.1002/phar.2610. [PMID] 34170559.
2021
Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction-A Systematic Review and Meta-analysis of Randomized Trials.
CJC open. 3(1):101-108 [DOI] 10.1016/j.cjco.2020.09.005. [PMID] 33458636.
2021
Emerging role of machine learning in cardiovascular disease investigation and translations.
American heart journal plus : cardiology research and practice. 11 [DOI] 10.1016/j.ahjo.2021.100050. [PMID] 38559318.
2021
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations.
American heart journal. 241:38-49 [DOI] 10.1016/j.ahj.2021.06.013. [PMID] 34224684.
2021
Erratum to “Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era” AmJMed, 133(11); 1254-1261.
The American journal of medicine. 134(4) [DOI] 10.1016/j.amjmed.2021.01.001. [PMID] 33461734.
2021
Functional heart recovery in an adult mammal, the spiny mouse.
International journal of cardiology. 338:196-203 [DOI] 10.1016/j.ijcard.2021.06.015. [PMID] 34126132.
2021
Impact of a preventive cardiology clinic focusing on lifestyle and nutrition counseling: A pilot analysis.
American heart journal plus : cardiology research and practice. 6 [DOI] 10.1016/j.ahjo.2021.100032. [PMID] 38560555.
2021
Insights to advance our management of myocardial ischemia: From obstructive epicardial disease to functional coronary alterations.
American heart journal plus : cardiology research and practice. 11 [DOI] 10.1016/j.ahjo.2021.100060. [PMID] 38559316.
2021
Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis.
Frontiers in cardiovascular medicine. 8 [DOI] 10.3389/fcvm.2021.645122. [PMID] 33996940.
2021
Left ventricular circumferential strain and coronary microvascular dysfunction: A report from the Women’s Ischemia Syndrome Evaluation Coronary Vascular Dysfunction (WISE-CVD) Project.
International journal of cardiology. 327:25-30 [DOI] 10.1016/j.ijcard.2020.11.006. [PMID] 33202262.
2021
Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design.
American journal of nephrology. 52(1):36-44 [DOI] 10.1159/000513567. [PMID] 33640890.
2021
Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 3/5.
Journal of the American College of Cardiology. 77(14):1799-1812 [DOI] 10.1016/j.jacc.2021.01.057. [PMID] 33832606.
2021
Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.
Journal of the American College of Cardiology. 77(14):1778-1798 [DOI] 10.1016/j.jacc.2021.02.026. [PMID] 33832605.
2021
Maternal Stroke
Circulation. 143(7):727-738 [DOI] 10.1161/circulationaha.120.051460. [PMID] 33587666.
2021
Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center.
Cardio-oncology (London, England). 7(1) [DOI] 10.1186/s40959-021-00097-9. [PMID] 33736707.
2021
Peak Systolic Blood Pressure During the Exercise Test: Reference Values by Sex and Age and Association With Mortality.
Hypertension (Dallas, Tex. : 1979). 77(6):1906-1914 [DOI] 10.1161/HYPERTENSIONAHA.120.16570. [PMID] 33866799.
2021
Perfusion, cryopreservation, and nanowarming of whole hearts using colloidally stable magnetic cryopreservation agent solutions.
Science advances. 7(2) [DOI] 10.1126/sciadv.abe3005. [PMID] 33523997.
2021
Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial.
Frontiers in cardiovascular medicine. 8 [DOI] 10.3389/fcvm.2021.698088. [PMID] 34540912.
2021
Phytoestrogen blood levels and adverse outcomes in women with suspected ischemic heart disease.
European journal of clinical nutrition. 75(5):829-835 [DOI] 10.1038/s41430-020-00800-6.
2021
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort.
International journal of cardiology. 326:131-138 [DOI] 10.1016/j.ijcard.2020.10.043. [PMID] 33091520.
2021
Potential of Minocycline for Treatment of Resistant Hypertension.
The American journal of cardiology. 156:147-149 [DOI] 10.1016/j.amjcard.2021.07.004. [PMID] 34348841.
2021
Preparticipation Cardiac Evaluation Findings in a Cohort of Collegiate Female Athletes.
The American journal of cardiology. 140:134-139 [DOI] 10.1016/j.amjcard.2020.10.055. [PMID] 33144161.
2021
Prior Oral Contraceptive Use and Longer Term Mortality Outcomes in Women with Suspected Ischemic Heart Disease.
Journal of women's health (2002). 30(3):377-384 [DOI] 10.1089/jwh.2020.8743. [PMID] 33481672.
2021
Rationale and design of the Women’s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial.
American heart journal. 237:90-103 [DOI] 10.1016/j.ahj.2021.03.011. [PMID] 33745898.
2021
Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project.
Vessel plus. 5 [DOI] 10.20517/2574-1209.2021.55. [PMID] 35530745.
2021
Reply to “Angiotensin-converting enzyme 2, sex differences, and COVID-19: The missing link”.
International journal of cardiology. 328 [DOI] 10.1016/j.ijcard.2020.11.058. [PMID] 33248187.
2021
Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
International journal of cardiology. 328:218-219 [DOI] 10.1016/j.ijcard.2020.12.032. [PMID] 33359280.
2021
Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease.
American heart journal plus : cardiology research and practice. 8 [DOI] 10.1016/j.ahjo.2021.100035. [PMID] 38558849.
2021
Sex and gender differences in COVID-19: More to be learned!
American heart journal plus : cardiology research and practice. 3 [DOI] 10.1016/j.ahjo.2021.100011. [PMID] 34169297.
2021
Sex Differences, Aspirin, and Primary Prevention.
The American journal of medicine. 134(1):9-10 [DOI] 10.1016/j.amjmed.2020.08.014. [PMID] 32941847.
2021
Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women’s Ischemia Syndrome Evaluation.
Heart and mind (Mumbai, India). 5(4):112-118 [DOI] 10.4103/hm.hm_34_21. [PMID] 34966880.
2021
Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia.
The American journal of medicine. 134(11):1321-1329 [DOI] 10.1016/j.amjmed.2021.06.038. [PMID] 34343507.
2021
The Clinical Spectrum of Myocardial Infarction and Ischemia With Nonobstructive Coronary Arteries in Women.
JACC. Cardiovascular imaging. 14(5):1053-1062 [DOI] 10.1016/j.jcmg.2020.06.044. [PMID] 33011128.
2021
The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.
International journal of cardiology. 336:1-7 [DOI] 10.1016/j.ijcard.2021.05.045. [PMID] 34087335.
2021
Women and atrial fibrillation.
Journal of cardiovascular electrophysiology. 32(10):2793-2807 [DOI] 10.1111/jce.14838. [PMID] 33332669.
2020
A Cardio-Obstetric Approach to Management of the Complex Pregnant Cardiac Patient.
JACC. Case reports. 2(1):86-90 [DOI] 10.1016/j.jaccas.2019.12.008. [PMID] 34316971.
2020
ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
Hypertension (Dallas, Tex. : 1979). 76(3):651-661 [DOI] 10.1161/HYPERTENSIONAHA.120.15595. [PMID] 32783758.
2020
Acute Stroke During Pregnancy and Puerperium.
Journal of the American College of Cardiology. 75(2):180-190 [DOI] 10.1016/j.jacc.2019.10.056. [PMID] 31948647.
2020
Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Journal of women's health (2002). 29(4):487-492 [DOI] 10.1089/jwh.2019.7925. [PMID] 31859580.
2020
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC. CardioOncology. 2(4):581-595 [DOI] 10.1016/j.jaccao.2020.09.001. [PMID] 33403362.
2020
Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension.
Hypertension (Dallas, Tex. : 1979). 75(4):1063-1071 [DOI] 10.1161/HYPERTENSIONAHA.119.14294. [PMID] 32088998.
2020
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women’s Ischemia Syndrome Evaluation) Study.
Journal of the American Heart Association. 9(4) [DOI] 10.1161/JAHA.119.013168. [PMID] 32063125.
2020
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.
JACC. Cardiovascular interventions. 13(16):1847-1864 [DOI] 10.1016/j.jcin.2020.05.052. [PMID] 32819476.
2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events
Circulation. 142(6):546-555 [DOI] 10.1161/circulationaha.119.045526. [PMID] 32654539.
2020
Attended vs unattended systolic blood pressure measurement: A randomized comparison in patients with cardiovascular disease.
Journal of clinical hypertension (Greenwich, Conn.). 22(11):1987-1992 [DOI] 10.1111/jch.14037. [PMID] 32951360.
2020
Cardiac stem cell therapy among Clinics of Uncertain Regulatory Status (COURS): under-regulated, under-observed, incompletely understood.
Journal of translational medicine. 18(1) [DOI] 10.1186/s12967-020-02425-6. [PMID] 32678051.
2020
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era.
The American journal of medicine. 133(11):1254-1261 [DOI] 10.1016/j.amjmed.2020.06.005. [PMID] 32653420.
2020
Cell Therapy Strategies With No Safety Concerns and Demonstrated Benefits Warrant Study.
Circulation journal : official journal of the Japanese Circulation Society. 84(11):2120-2121 [DOI] 10.1253/circj.CJ-19-1175. [PMID] 33041288.
2020
Commentary – The ISCHEMIA trial.
International journal of cardiology. 304:1-4 [DOI] 10.1016/j.ijcard.2020.02.011. [PMID] 32059992.
2020
Coronary Vascular Function and Cardiomyocyte Injury
Arteriosclerosis, Thrombosis, and Vascular Biology. 40(12):3015-3021 [DOI] 10.1161/atvbaha.120.314260. [PMID] 33028098.
2020
Design, methodology and baseline characteristics of the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
American heart journal. 220:224-236 [DOI] 10.1016/j.ahj.2019.11.017. [PMID] 31884245.
2020
Even “WISE-R?”-an Update on the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation.
Current atherosclerosis reports. 22(8) [DOI] 10.1007/s11883-020-00852-w. [PMID] 32556630.
2020
Heart failure with preserved ejection fraction: Similarities and differences between women and men.
International journal of cardiology. 304:101-108 [DOI] 10.1016/j.ijcard.2020.01.003. [PMID] 31959407.
2020
Immune Dysregulation in HFpEF: A Target for Mesenchymal Stem/Stromal Cell Therapy.
Journal of clinical medicine. 9(1) [DOI] 10.3390/jcm9010241. [PMID] 31963368.
2020
International prospective cohort study of microvascular angina – Rationale and design.
International journal of cardiology. Heart & vasculature. 31 [DOI] 10.1016/j.ijcha.2020.100630. [PMID] 32984497.
2020
Invasive Functional Assessment in Patients With Angina and Coronary Microvascular Dysfunction: A Plea for More.
Journal of the American College of Cardiology. 75(20):2550-2552 [DOI] 10.1016/j.jacc.2020.03.052. [PMID] 32439004.
2020
Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy.
Open heart. 7(2) [DOI] 10.1136/openhrt-2020-001273. [PMID] 32763966.
2020
Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring.
Hypertension (Dallas, Tex. : 1979). 75(5):1315-1324 [DOI] 10.1161/HYPERTENSIONAHA.120.14736. [PMID] 32200676.
2020
Myocardial Infarction and Persistent Angina With No Obstructive Coronary Artery Disease.
JACC. Case reports. 2(1):9-14 [DOI] 10.1016/j.jaccas.2019.11.049. [PMID] 34316956.
2020
Myocardial ischemia: From disease to syndrome.
International journal of cardiology. 314:32-35 [DOI] 10.1016/j.ijcard.2020.04.074. [PMID] 32348810.
2020
N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
PloS one. 15(12) [DOI] 10.1371/journal.pone.0243213. [PMID] 33270715.
2020
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE).
International journal of cardiology. Heart & vasculature. 27 [DOI] 10.1016/j.ijcha.2020.100502. [PMID] 32226820.
2020
Optimal systolic blood pressure and reduced long-term mortality in older hypertensive women with prior coronary events – An analysis from INVEST☆.
International Journal of Cardiology. Hypertension. 7 [DOI] 10.1016/j.ijchy.2020.100052. [PMID] 33817619.
2020
Oxidative Stress Is Associated With Diastolic Dysfunction in Women With Ischemia With No Obstructive Coronary Artery Disease.
Journal of the American Heart Association. 9(10) [DOI] 10.1161/JAHA.119.015602. [PMID] 32375556.
2020
Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women’s Ischemia Syndrome Evaluation).
Journal of the American Heart Association. 9(7) [DOI] 10.1161/JAHA.119.013234. [PMID] 32268814.
2020
Psychological stress, cardiac symptoms, and cardiovascular risk in women with suspected ischaemia but no obstructive coronary disease.
Stress and health : journal of the International Society for the Investigation of Stress. 36(3):264-273 [DOI] 10.1002/smi.2928. [PMID] 31957961.
2020
Redefining Resistant Hypertension: A Comparison of Cardiovascular Risk Associated With the 2018 Versus 2008 American Heart Association Definitions for Resistant Hypertension.
Circulation. Cardiovascular quality and outcomes. 13(2) [DOI] 10.1161/CIRCOUTCOMES.119.005979. [PMID] 32008359.
2020
Reply: Factors Associated With Acute Stroke During Pregnancy and Puerperium.
Journal of the American College of Cardiology. 75(17):2280-2281 [DOI] 10.1016/j.jacc.2020.03.014. [PMID] 32354396.
2020
Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
International journal of cardiology. 309:19-22 [DOI] 10.1016/j.ijcard.2020.01.053. [PMID] 32037132.
2020
Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST).
Journal of women's health (2002). 29(2):158-166 [DOI] 10.1089/jwh.2018.7235. [PMID] 31403360.
2020
Statin Use for Atherosclerotic Cardiovascular Disease Prevention Among Sexual Minority Adults
Journal of the American Heart Association. 9(24) [DOI] 10.1161/jaha.120.018233. [PMID] 33317368.
2020
Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
Journal of the American College of Cardiology. 75(20):2602-2618 [DOI] 10.1016/j.jacc.2020.03.060. [PMID] 32439010.
2020
Systolic blood pressure, heart rate, and outcomes in patients with coronary disease and heart failure.
ESC heart failure. 7(1):123-129 [DOI] 10.1002/ehf2.12534. [PMID] 31840441.
2020
Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVD.
Journal of the American Heart Association. 9(13) [DOI] 10.1161/JAHA.119.016305. [PMID] 32578481.
2020
Thiazide Exposure and Cardiovascular Risk in Type 2 Diabetes Mellitus: A Point of Clarification.
Hypertension (Dallas, Tex. : 1979). 75(3):e2-e5 [DOI] 10.1161/HYPERTENSIONAHA.119.14447. [PMID] 32008437.
2020
Transcriptomic signature of gut microbiome-contacting cells in colon of spontaneously hypertensive rats.
Physiological genomics. 52(3):121-132 [DOI] 10.1152/physiolgenomics.00087.2019. [PMID] 31869283.
2020
Treatment of coronary microvascular dysfunction.
Cardiovascular research. 116(4):856-870 [DOI] 10.1093/cvr/cvaa006. [PMID] 32087007.
2020
What is the Real Message of the ISCHEMIA Trial from a Clinician’s Perspective?
European cardiology. 15 [DOI] 10.15420/ecr.2020.27. [PMID] 32983263.
2020
Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.
International journal of cardiology. 315:105-106 [DOI] 10.1016/j.ijcard.2020.05.026. [PMID] 32418736.
2020
Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19?
Frontiers in neuroscience. 14 [DOI] 10.3389/fnins.2020.577780. [PMID] 33117121.
2019
Adenosine vs Regadenoson Pharmacologic Stress Differs in Women with Suspected Coronary Microvascular Dysfunction: A Report from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) Study.
Cardiovascular disorder and medicine. 2019 [DOI] 10.31487/j.cdm.2019.01.01. [PMID] 36913201.
2019
Advances in small-molecule therapy for managing angina pectoris in the elderly.
Expert opinion on pharmacotherapy. 20(12):1471-1481 [DOI] 10.1080/14656566.2019.1615881. [PMID] 31107109.
2019
Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation.
Journal of the American Heart Association. 8(12) [DOI] 10.1161/JAHA.119.012406. [PMID] 31165670.
2019
Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.
Circulation. Genomic and precision medicine. 12(4) [DOI] 10.1161/CIRCGEN.119.002471. [PMID] 30897348.
2019
Complementary Embryonic and Adult Cell Populations Enhance Myocardial Repair in Rat Myocardial Injury Model.
Stem cells international. 2019 [DOI] 10.1155/2019/3945850. [PMID] 31781239.
2019
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients.
JACC. Basic to translational science. 4(6):659-669 [DOI] 10.1016/j.jacbts.2019.07.012. [PMID] 31709316.
2019
Gender in cardiovascular medicine: chest pain and coronary artery disease.
European Heart Journal. 40(47):3819-3826 [DOI] 10.1093/eurheartj/ehz784. [PMID] 31713592.
2019
Genome-wide association analysis of common genetic variants of resistant hypertension
The pharmacogenomics journal. 19(3):295-304 [DOI] 10.1038/s41397-018-0049-x. [PMID] 30237584.
2019
Genome-Wide Meta-Analysis of Blood Pressure Response to β1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
Journal of the American Heart Association. 8(16) [DOI] 10.1161/JAHA.119.013115. [PMID] 31423876.
2019
Heart Failure With Preserved Ejection Fraction: Is Ischemia Due to Coronary Microvascular Dysfunction a Mechanistic Factor?
The American journal of medicine. 132(6):692-697 [DOI] 10.1016/j.amjmed.2018.12.038. [PMID] 30684452.
2019
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
Journal of the American College of Cardiology. 73(6):684-693 [DOI] 10.1016/j.jacc.2018.11.040. [PMID] 30765035.
2019
Impaired Autonomic Nervous System-Microbiome Circuit in Hypertension.
Circulation research. 125(1):104-116 [DOI] 10.1161/CIRCRESAHA.119.313965. [PMID] 31219753.
2019
Incidence, prevalence, and predictors of treatment-resistant hypertension with intensive blood pressure lowering.
Journal of clinical hypertension (Greenwich, Conn.). 21(6):825-834 [DOI] 10.1111/jch.13550. [PMID] 31066177.
2019
Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC).
BMJ open. 9(5) [DOI] 10.1136/bmjopen-2018-028698. [PMID] 31123005.
2019
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
International journal of cardiology. 276:8-13 [DOI] 10.1016/j.ijcard.2018.09.081. [PMID] 30293664.
2019
Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.
European heart journal. Cardiovascular Imaging. 20(8):875-882 [DOI] 10.1093/ehjci/jez044. [PMID] 30904924.
2019
Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
JAMA network open. 2(12) [DOI] 10.1001/jamanetworkopen.2019.18425. [PMID] 31880802.
2019
Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
European heart journal. 40(29):2455-2462 [DOI] 10.1093/eurheartj/ehy857. [PMID] 30608528.
2019
Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.
Circulation research. 124(11):1520-1535 [DOI] 10.1161/CIRCRESAHA.118.313568. [PMID] 31120824.
2019
Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension.
Circulation research. 124(5):727-736 [DOI] 10.1161/CIRCRESAHA.118.313882. [PMID] 30612527.
2019
Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women.
Journal of the American Heart Association. 8(22) [DOI] 10.1161/JAHA.119.014546. [PMID] 31707945.
2019
Novel Self-Report Tool for Cardiovascular Risk Assessment.
Journal of the American Heart Association. 8(24) [DOI] 10.1161/JAHA.119.014123. [PMID] 31818214.
2019
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
Journal of interventional cardiology. 2019 [DOI] 10.1155/2019/7169275. [PMID] 31772544.
2019
Sex and Race/Ethnicity Differences in Atrial Fibrillation.
Journal of the American College of Cardiology. 74(22):2812-2815 [DOI] 10.1016/j.jacc.2019.09.045. [PMID] 31779796.
2019
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Journal of the American Heart Association. 8(19) [DOI] 10.1161/JAHA.119.013154. [PMID] 31549581.
2019
Subsequent Event Risk in Individuals With Established Coronary Heart Disease.
Circulation. Genomic and precision medicine. 12(4) [DOI] 10.1161/CIRCGEN.119.002470. [PMID] 30896328.
2019
Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat.
Journal of the American Heart Association. 8(4) [DOI] 10.1161/JAHA.118.010721. [PMID] 30755073.
2019
β2 -Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies.
Journal of clinical pharmacology. 59(11):1462-1470 [DOI] 10.1002/jcph.1443. [PMID] 31090079.
2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.
Scientific reports. 8(1) [DOI] 10.1038/s41598-018-22121-2. [PMID] 29511207.
2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.
PLoS medicine. 15(3) [DOI] 10.1371/journal.pmed.1002538. [PMID] 29558462.
2018
Extent of coronary atherosclerosis and arterial remodelling in women: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Cardiovascular diagnosis and therapy. 8(4):405-413 [DOI] 10.21037/cdt.2018.04.03. [PMID] 30214855.
2018
Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes.
The pharmacogenomics journal. 18(1):106-112 [DOI] 10.1038/tpj.2016.67. [PMID] 27670767.
2018
Gut microbiota and serum metabolite differences in African Americans and White Americans with high blood pressure.
International journal of cardiology. 271:336-339 [DOI] 10.1016/j.ijcard.2018.04.074. [PMID] 30049487.
2018
High sensitivity cardiac troponin T and I and risk stratification of patients with stable CHD: Is it time to incorporate this in routine clinical practice?
International journal of cardiology. 250:266-267 [DOI] 10.1016/j.ijcard.2017.10.007. [PMID] 29169758.
2018
Hypertension Across a Woman’s Life Cycle.
Journal of the American College of Cardiology. 71(16):1797-1813 [DOI] 10.1016/j.jacc.2018.02.033. [PMID] 29673470.
2018
Hypertension in Florida: Data From the OneFlorida Clinical Data Research Network.
Preventing chronic disease. 15 [DOI] 10.5888/pcd15.170332. [PMID] 29494332.
2018
Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice.
Clinical cardiology. 41(2):220-227 [DOI] 10.1002/clc.22892. [PMID] 29485737.
2018
Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
Clinical science (London, England : 1979). 132(6):701-718 [DOI] 10.1042/CS20180087. [PMID] 29507058.
2018
Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression.
Gut. 67(8):1555-1557 [DOI] 10.1136/gutjnl-2017-314759. [PMID] 28814485.
2018
Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.
Journal of clinical hypertension (Greenwich, Conn.). 20(4):620-624 [DOI] 10.1111/jch.13247. [PMID] 29532983.
2018
Intracoronary Bolus Injection Versus Intravenous Infusion of Adenosine for Assessment of Coronary Flow Velocity Reserve in Women With Signs and Symptoms of Myocardial Ischemia and No Obstructive Coronary Artery Disease.
JACC. Cardiovascular interventions. 11(20):2125-2127 [DOI] 10.1016/j.jcin.2018.07.052. [PMID] 30336817.
2018
Ischemia and No Obstructive Coronary Artery Disease ( INOCA ): What Is the Risk?
Journal of the American Heart Association. 7(17) [DOI] 10.1161/JAHA.118.008868. [PMID] 30371178.
2018
Long-term mortality and estimated functional capacity among women with symptoms of ischemic heart disease: From the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
American heart journal. 206:123-126 [DOI] 10.1016/j.ahj.2018.08.010. [PMID] 30237012.
2018
Maladaptive left ventricular remodeling in women: An analysis from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction study.
International journal of cardiology. 268:230-235 [DOI] 10.1016/j.ijcard.2018.03.139. [PMID] 30041793.
2018
Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Journal of hypertension. 36(2):419-427 [DOI] 10.1097/HJH.0000000000001559. [PMID] 28938338.
2018
Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Circulation. 137(8):874-876 [DOI] 10.1161/CIRCULATIONAHA.117.031999. [PMID] 29459474.
2018
Not All Stem Cells Are Created Equal.
Circulation research. 123(8):944-946 [DOI] 10.1161/CIRCRESAHA.118.313425. [PMID] 30355037.
2018
Optimal medical treatment of hypertension in patients with coronary artery disease.
Expert review of cardiovascular therapy. 16(11):815-823 [DOI] 10.1080/14779072.2018.1534069. [PMID] 30295548.
2018
Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD.
The American journal of medicine. 131(12):1463-1472.e7 [DOI] 10.1016/j.amjmed.2018.08.005. [PMID] 30142317.
2018
Prevalence, Causes, and Predictors of 30-Day Readmissions Following Hospitalization With Acute Myocardial Infarction Complicated By Cardiogenic Shock: Findings From the 2013-2014 National Readmissions Database.
Journal of the American Heart Association. 7(6) [DOI] 10.1161/JAHA.117.008235. [PMID] 29572325.
2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circulation research. 122(12):1703-1715 [DOI] 10.1161/CIRCRESAHA.118.312978. [PMID] 29703749.
2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
American heart journal. 201:54-62 [DOI] 10.1016/j.ahj.2018.02.009. [PMID] 29910056.
2018
Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative Medicine.
Stem cells translational medicine. 7(7):511-512 [DOI] 10.1002/sctm.18-0066. [PMID] 30403444.
2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design.
American heart journal. 201:141-148 [DOI] 10.1016/j.ahj.2018.03.016. [PMID] 29803986.
2018
The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
Nature reviews. Nephrology. 14(7):442-456 [DOI] 10.1038/s41581-018-0018-2. [PMID] 29760448.
2018
The Reply.
The American journal of medicine. 131(2) [DOI] 10.1016/j.amjmed.2017.10.025. [PMID] 29362110.
2018
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis.
Circulation research. 122(3):479-488 [DOI] 10.1161/CIRCRESAHA.117.311466. [PMID] 29208679.
2018
Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors.
Cardiovascular toxicology. 18(2):184-191 [DOI] 10.1007/s12012-017-9429-8. [PMID] 29022233.
2018
Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).
Clinical cardiology. 41(2):185-193 [DOI] 10.1002/clc.22894. [PMID] 29498752.
2017
Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function.
PloS one. 12(2) [DOI] 10.1371/journal.pone.0172538. [PMID] 28207868.
2017
Advancements in pharmacotherapy for angina.
Expert opinion on pharmacotherapy. 18(5):457-469 [DOI] 10.1080/14656566.2017.1303483. [PMID] 28264619.
2017
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Cardiovascular diagnosis and therapy. 7(3):288-295 [DOI] 10.21037/cdt.2017.03.07. [PMID] 28567354.
2017
Blood pressure, heart rate, and double product: lessons learned from Japan.
Journal of hypertension. 35(9):1785-1786 [DOI] 10.1097/HJH.0000000000001403. [PMID] 28767488.
2017
Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability.
Circulation research. 121(10):1116-1118 [DOI] 10.1161/CIRCRESAHA.117.311947. [PMID] 29074527.
2017
Cardiovascular safety of NSAIDs: Additional insights after PRECISION and point of view.
Clinical cardiology. 40(12):1352-1356 [DOI] 10.1002/clc.22814. [PMID] 29247518.
2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy.
Scientific reports. 7(1) [DOI] 10.1038/s41598-017-04801-7. [PMID] 28667255.
2017
Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD.
PloS one. 12(1) [DOI] 10.1371/journal.pone.0169818. [PMID] 28081214.
2017
Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.
JMIR research protocols. 6(12) [DOI] 10.2196/resprot.8057. [PMID] 29263019.
2017
Effect of Low-Furanocoumarin Hybrid Grapefruit Juice Consumption on Midazolam Pharmacokinetics.
Journal of clinical pharmacology. 57(3):305-311 [DOI] 10.1002/jcph.807. [PMID] 27503364.
2017
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation. 135(15):1417-1428 [DOI] 10.1161/CIRCULATIONAHA.116.025707. [PMID] 28209728.
2017
Fertility Therapy and Long-Term Cardiovascular Risk: Raising More Questions Than Answers?
Journal of the American College of Cardiology. 70(10):1214-1215 [DOI] 10.1016/j.jacc.2017.07.731. [PMID] 28859783.
2017
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms.
Nature genetics. 49(7):1113-1119 [DOI] 10.1038/ng.3874. [PMID] 28530674.
2017
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Journal of the American Heart Association. 6(11) [DOI] 10.1161/JAHA.117.006522. [PMID] 29097388.
2017
Gut Microbiota: Potential for a Unifying Hypothesis for Prevention and Treatment of Hypertension.
Circulation research. 120(11):1724-1726 [DOI] 10.1161/CIRCRESAHA.117.310734. [PMID] 28546357.
2017
Hypertension-Linked Pathophysiological Alterations in the Gut.
Circulation research. 120(2):312-323 [DOI] 10.1161/CIRCRESAHA.116.309006. [PMID] 27799253.
2017
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic research in cardiology. 112(1) [PMID] 27882430.
2017
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 12(5) [DOI] 10.1371/journal.pone.0177684. [PMID] 28542263.
2017
Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging.
Journal of the American Medical Directors Association. 18(9):810.e1-810.e4 [DOI] 10.1016/j.jamda.2017.05.018. [PMID] 28676292.
2017
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
Circulation. 135(11):1075-1092 [DOI] 10.1161/CIRCULATIONAHA.116.024534. [PMID] 28289007.
2017
Menopausal symptoms and cardiovascular disease mortality in the Women’s Ischemia Syndrome Evaluation (WISE).
Menopause (New York, N.Y.). 24(2):126-132 [DOI] 10.1097/GME.0000000000000731. [PMID] 27676638.
2017
Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women’s Ischemia Syndrome Evaluation.
The American journal of medicine. 130(6):738-743 [DOI] 10.1016/j.amjmed.2016.12.028. [PMID] 28109970.
2017
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.
Clinical cardiology. 40(5):300-306 [DOI] 10.1002/clc.22660. [PMID] 28004395.
2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function.
Circulation research. 120(12):1947-1957 [DOI] 10.1161/CIRCRESAHA.116.309947. [PMID] 28490433.
2017
Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.
Journal of the American College of Cardiology. 70(3):373-388 [DOI] 10.1016/j.jacc.2017.05.051. [PMID] 28705320.
2017
Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions.
Hypertension (Dallas, Tex. : 1979). [DOI] 10.1161/HYPERTENSIONAHA.117.09699. [PMID] 28760940.
2017
Resistant Hypertension: Mechanisms and Treatment.
Current hypertension reports. 19(7) [DOI] 10.1007/s11906-017-0754-x. [PMID] 28597403.
2017
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women’s Ischemia Syndrome Evaluation Study.
Journal of the American Heart Association. 6(8) [DOI] 10.1161/JAHA.117.005501. [PMID] 28862961.
2017
Systolic blood pressure target: Have we identified the optimal target yet?
Journal of public health and emergency. 1 [DOI] 10.21037/jphe.2017.06.04. [PMID] 30148257.
2017
Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation).
Circulation. Cardiovascular quality and outcomes. 10(12) [DOI] 10.1161/CIRCOUTCOMES.116.003863. [PMID] 29217675.
2017
The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 89(2):169-177 [DOI] 10.1002/ccd.26601. [PMID] 27148802.
2017
The Gut, Its Microbiome, and Hypertension.
Current hypertension reports. 19(4) [DOI] 10.1007/s11906-017-0734-1. [PMID] 28444579.
2017
Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve.
Clinical cardiology. 40(10):886-891 [DOI] 10.1002/clc.22740. [PMID] 28605043.
2016
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
European heart journal. 37(19):1504-13 [DOI] 10.1093/eurheartj/ehv647. [PMID] 26614823.
2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats.
International journal of cardiology. 220:149-54 [DOI] 10.1016/j.ijcard.2016.06.158. [PMID] 27379917.
2016
Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia.
Journal of molecular medicine (Berlin, Germany). 94(1):37-49 [PMID] 26498282.
2016
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.
Texas Heart Institute journal. 43(4):291-6 [DOI] 10.14503/THIJ-15-5341. [PMID] 27547135.
2016
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
Cell transplantation. 25(9):1701-1711 [PMID] 27151378.
2016
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
American heart journal. 179:142-50 [DOI] 10.1016/j.ahj.2016.06.018. [PMID] 27595689.
2016
Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.
Circulation research. 118(8):1327-36 [DOI] 10.1161/CIRCRESAHA.116.307709. [PMID] 27081113.
2016
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome.
Journal of women's health (2002). 25(9):875-81 [DOI] 10.1089/jwh.2015.5441. [PMID] 27267867.
2016
CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.
European journal of clinical pharmacology. 72(6):681-7 [DOI] 10.1007/s00228-016-2029-x. [PMID] 26915813.
2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction Study (WISE-CVD).
Atherosclerosis. 253:111-117 [DOI] 10.1016/j.atherosclerosis.2016.08.026. [PMID] 27596135.
2016
Correction: Effects of Verapamil SR and Atenolol on 24-Hour Blood Pressure and Heart Rate in Hypertension Patients with Coronary Artery Disease: An International Verapamil SR-Trandolapril Ambulatory Monitoring Substudy.
PloS one. 11(6) [DOI] 10.1371/journal.pone.0157212. [PMID] 27258057.
2016
Experimental and early investigational drugs for angina pectoris.
Expert opinion on investigational drugs. 25(12):1413-1421 [PMID] 27791405.
2016
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women.
Physiological genomics. 48(1):12-20 [DOI] 10.1152/physiolgenomics.00067.2015. [PMID] 26534935.
2016
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women’s ischemia syndrome evaluation study.
International journal of cardiology. 223:936-939 [DOI] 10.1016/j.ijcard.2016.07.301. [PMID] 27589041.
2016
Hypertension-linked mechanical changes of rat gut.
Acta biomaterialia. 45:296-302 [DOI] 10.1016/j.actbio.2016.08.045. [PMID] 27567964.
2016
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Cell transplantation. 25(9):1675-1687 [PMID] 26590374.
2016
Ischemic Predictors of Outcomes in Women With Signs and Symptoms of Ischemia and Nonobstructive Coronary Artery Disease.
JAMA cardiology. 1(4):491-2 [DOI] 10.1001/jamacardio.2016.0740. [PMID] 27438329.
2016
Long-Term Mortality in Hypertensive Patients With Coronary Artery Disease: Results From the US Cohort of the International Verapamil (SR)/Trandolapril Study.
Hypertension (Dallas, Tex. : 1979). 68(5):1110-1114 [PMID] 27620390.
2016
Mental Stress and Myocardial Ischemia: Young Women at Risk.
Journal of the American Heart Association. 5(9) [DOI] 10.1161/JAHA.116.004196. [PMID] 27559073.
2016
Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women’s Heart Disease.
Journal of women's health (2002). 25(10):996-1003 [PMID] 27224417.
2016
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.
JACC. Cardiovascular imaging. 9(4):421-35 [DOI] 10.1016/j.jcmg.2016.01.004. [PMID] 27056162.
2016
Predictors of short- and long-term mortality in hospitalized veterans with elevated troponin.
Journal of hospital medicine. 11(11):773-777 [DOI] 10.1002/jhm.2619. [PMID] 27256219.
2016
Psychosocial predictors of long-term mortality among women with suspected myocardial ischemia: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Journal of behavioral medicine. 39(4):687-93 [DOI] 10.1007/s10865-016-9737-7. [PMID] 27017335.
2016
Reply: Association Between Migraine Headache and Cardiac Syndrome X.
Journal of the American College of Cardiology. 67(17) [DOI] 10.1016/j.jacc.2016.01.074. [PMID] 27126542.
2016
Safety of Routine Invasive Versus Selective Invasive Therapy in Women with Non-ST-Elevation Acute Coronary Syndrome.
Cardiology and therapy. 5(1):43-50 [DOI] 10.1007/s40119-015-0055-x. [PMID] 26661893.
2016
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.
JACC. Basic to translational science. 1(6):510-523 [DOI] 10.1016/j.jacbts.2016.06.010. [PMID] 28580434.
2016
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE).
Cardiovascular diagnosis and therapy. 6(5):424-431 [PMID] 27747165.
2016
Women, Hypertension, and the Systolic Blood Pressure Intervention Trial.
The American journal of medicine. 129(10):1030-6 [DOI] 10.1016/j.amjmed.2016.06.022. [PMID] 27427323.
2015
Acute kidney injury after transcatheter aortic valve replacement.
American journal of nephrology. 41(4-5):370-1 [DOI] 10.1159/000431340. [PMID] 26113253.
2015
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.
Cardiovascular drugs and therapy. 29(4):391-401 [DOI] 10.1007/s10557-015-6597-2. [PMID] 26037616.
2015
Angina treatments and prevention of cardiac events: an appraisal of the evidence.
European heart journal supplements : journal of the European Society of Cardiology. 17(Suppl G):G10-G18 [PMID] 26740801.
2015
Assessing cardiovascular risk in women: looking beyond traditional risk factors.
Trends in cardiovascular medicine. 25(2):152-3 [DOI] 10.1016/j.tcm.2014.10.024. [PMID] 25468290.
2015
Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: An ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 170(6):1243-54 [DOI] 10.1016/j.ahj.2015.08.019. [PMID] 26678647.
2015
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circulation research. 116(1):99-107 [DOI] 10.1161/CIRCRESAHA.116.304710. [PMID] 25406300.
2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women’s Ischemia Syndrome Evaluation.
Circulation. Cardiovascular imaging. 8(4) [DOI] 10.1161/CIRCIMAGING.114.002481. [PMID] 25801710.
2015
Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
PloS one. 10(4) [DOI] 10.1371/journal.pone.0122726. [PMID] 25835002.
2015
Efficacy and safety of angiotensin receptor blockers in older patients: a meta-analysis of randomized trials.
American journal of hypertension. 28(5):576-85 [DOI] 10.1093/ajh/hpu209. [PMID] 25391580.
2015
Emergence of Nonobstructive Coronary Artery Disease: A Woman’s Problem and Need for Change in Definition on Angiography.
Journal of the American College of Cardiology. 66(17):1918-33 [DOI] 10.1016/j.jacc.2015.08.876. [PMID] 26493665.
2015
Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
JRSM open. 6(3) [DOI] 10.1177/2054270415577761. [PMID] 25893110.
2015
Gut dysbiosis is linked to hypertension.
Hypertension (Dallas, Tex. : 1979). 65(6):1331-40 [DOI] 10.1161/HYPERTENSIONAHA.115.05315. [PMID] 25870193.
2015
Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension – A case report.
International journal of cardiology. 201:157-8 [DOI] 10.1016/j.ijcard.2015.07.078. [PMID] 26301638.
2015
Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort.
The American journal of medicine. 128(2):137-43 [DOI] 10.1016/j.amjmed.2014.09.028. [PMID] 25447610.
2015
Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014?
Trends in cardiovascular medicine. 25(2):98-103 [DOI] 10.1016/j.tcm.2014.09.013. [PMID] 25454903.
2015
Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 169(3):412-8 [DOI] 10.1016/j.ahj.2014.12.010. [PMID] 25728732.
2015
Multiple causes for ischemia without obstructive coronary artery disease: not a short list.
Circulation. 131(12):1044-6 [DOI] 10.1161/CIRCULATIONAHA.115.015553. [PMID] 25712204.
2015
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
Journal of hypertension. 33(11):2278-85 [DOI] 10.1097/HJH.0000000000000714. [PMID] 26425837.
2015
Recognizing Sex Similarities in Cardiovascular Disease Research.
Journal of the American College of Cardiology. 65(19):2152-3 [DOI] 10.1016/j.jacc.2015.02.066. [PMID] 25975483.
2015
Relationships between components of metabolic syndrome and coronary intravascular ultrasound atherosclerosis measures in women without obstructive coronary artery disease: the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation Study.
Cardiovascular endocrinology. 4(2):45-52 [PMID] 26665010.
2015
Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.
PloS one. 10(5) [DOI] 10.1371/journal.pone.0125374. [PMID] 25951606.
2015
The Coronary Microcirculation in STEMI: The Next Frontier?
European heart journal. 36(45):3178-81 [DOI] 10.1093/eurheartj/ehv495. [PMID] 26409009.
2014
2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.
Journal of the American College of Cardiology. 64(8):784-93 [DOI] 10.1016/j.jacc.2014.05.044. [PMID] 25145522.
2014
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations.
Journal of the American College of Cardiology. 64(4):394-402 [DOI] 10.1016/j.jacc.2014.06.014. [PMID] 25060376.
2014
A microvascular-myocardial diastolic dysfunctional state and risk for mental stress ischemia: a revised concept of ischemia during daily life.
JACC. Cardiovascular imaging. 7(4):362-5 [DOI] 10.1016/j.jcmg.2013.11.009. [PMID] 24742891.
2014
A Pharmacogenomic Genome-Wide Association Study (Gwas) for New Onset Diabetes (Nod) in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1):S59-S60
2014
A Pharmacogenomic Genome-Wide Association Study (Gwas) for New Onset Diabetes (Nod) in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1):S59-S60
2014
A Pharmacogenomic Genome-Wide Association Study for Adverse Cardiovascular Outcomes in the International Verapamil Sr-Trandolapril Study (Invest)
Clinical Pharmacology & Therapeutics. 95(1)
2014
A training program in cardiovascular cell-based therapy: from the NHLBI Cardiovascular Cell Therapy Research Network.
Regenerative medicine. 9(6):793-7 [DOI] 10.2217/rme.14.57. [PMID] 25431915.
2014
Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation.
American heart journal. 167(6):826-32 [DOI] 10.1016/j.ahj.2014.01.017. [PMID] 24890531.
2014
Atp2B1 Locus Is Associated With Resistant Hypertension in the International Verapamil Sr Tandolapril Study-Genetic Substudy (Investgenes)
Clinical Pharmacology & Therapeutics. 95(1):S26-S27
2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circulation research. 114(10):1564-8 [DOI] 10.1161/CIRCRESAHA.114.303720. [PMID] 24812350.
2014
Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Journal of the American Heart Association. 3(1) [DOI] 10.1161/JAHA.113.000660. [PMID] 24584740.
2014
Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
International journal of cardiology. 172(1):e114-5 [DOI] 10.1016/j.ijcard.2013.12.120. [PMID] 24461979.
2014
Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.
The American journal of medicine. 127(9):840-7 [DOI] 10.1016/j.amjmed.2014.04.011. [PMID] 24769297.
2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circulation research. 115(10):867-74 [DOI] 10.1161/CIRCRESAHA.115.304353. [PMID] 25136078.
2014
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
Journal of the American Heart Association. 3(6) [DOI] 10.1161/JAHA.114.001398. [PMID] 25385345.
2014
One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction.
JAMA. 311(3):301-2 [DOI] 10.1001/jama.2013.282674. [PMID] 24247415.
2014
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.
Journal of hypertension. 32(3):635-43 [DOI] 10.1097/HJH.0000000000000051. [PMID] 24299915.
2014
Proceedings from Duke resistant hypertension think tank.
American heart journal. 167(6):775-88.e1 [DOI] 10.1016/j.ahj.2014.02.008. [PMID] 24890525.
2014
Relationships Between Depression, Dietary Habits, and Cardiovascular Mortality and Events Among Women With Suspected Myocardial Ischemia
Psychosomatic Medicine. 76(3)
2014
Reply to ‘Resistant hypertension revisited: definition and true prevalence’.
Journal of hypertension. 32(7) [DOI] 10.1097/HJH.0000000000000220. [PMID] 24984184.
2014
Some thoughts on the continuing dilemma of angina pectoris.
European heart journal. 35(21):1361-4 [DOI] 10.1093/eurheartj/ehs225. [PMID] 23045268.
2014
The prevalence of microvascular dysfunction, its role among men, and links with adverse outcomes: noninvasive imaging reveals the tip of the iceberg.
Circulation. 129(24):2497-9 [DOI] 10.1161/CIRCULATIONAHA.114.010263. [PMID] 24787470.
2014
The Vascular Biology Working Group Twentieth Anniversary
. 35(27):1772-1773
2014
The Vascular Biology Working Group twentieth anniversary.
European heart journal. 35(27):1772-3 [PMID] 25157396.
2014
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 9(5) [DOI] 10.1371/journal.pone.0096630. [PMID] 24800739.
2014
Usefulness of Beta blockade in contemporary management of patients with stable coronary heart disease.
The American journal of cardiology. 114(10):1607-12 [DOI] 10.1016/j.amjcard.2014.08.026. [PMID] 25260949.
2013
A critical analysis of clinical outcomes reported in stem cell trials for acute myocardial infarction: some thoughts for design of future trials.
Current atherosclerosis reports. 15(8) [DOI] 10.1007/s11883-013-0341-9. [PMID] 23793731.
2013
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
American heart journal. 166(1):134-41 [DOI] 10.1016/j.ahj.2013.04.002. [PMID] 23816032.
2013
Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study.
Journal of the American Heart Association. 2(6) [DOI] 10.1161/JAHA.113.000257. [PMID] 24222666.
2013
Antagonist molecules in the treatment of angina.
Expert opinion on pharmacotherapy. 14(17):2323-42 [DOI] 10.1517/14656566.2013.834329. [PMID] 24047238.
2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
International journal of cardiology. 168(3):2335-40 [DOI] 10.1016/j.ijcard.2013.01.036. [PMID] 23410495.
2013
Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.
Journal of the American College of Cardiology. 61(9):957-70 [DOI] 10.1016/j.jacc.2012.10.051. [PMID] 23352782.
2013
Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment.
The pharmacogenomics journal. 13(5):430-6 [DOI] 10.1038/tpj.2012.34. [PMID] 22907731.
2013
Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.
Journal of hypertension. 31(4):698-704 [DOI] 10.1097/HJH.0b013e32835e2a71. [PMID] 23353631.
2013
Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome.
Acta diabetologica. 50(3):409-16 [DOI] 10.1007/s00592-012-0445-7. [PMID] 23188216.
2013
Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women’s ischemia Syndrome Evaluation (WISE) Study.
PloS one. 8(9) [DOI] 10.1371/journal.pone.0074585. [PMID] 24058592.
2013
Calcium Antagonists in the Treatment of Coronary Artery Disease
Current Opinion in Pharmacology. 13:301-308 [DOI] 10.1016/j.coph.2613.01.008.
2013
Calcium antagonists in the treatment of coronary artery disease.
Current opinion in pharmacology. 13(2):301-8 [DOI] 10.1016/j.coph.2013.01.008. [PMID] 23402734.
2013
Cardiovascular care for women: the 10-Q Report and beyond.
The American journal of cardiology. 112(4) [DOI] 10.1016/j.amjcard.2013.06.002. [PMID] 23910053.
2013
Clinical implications of the Women’s Ischemia Syndrome Evaluation: inter-relationships between symptoms, psychosocial factors and cardiovascular outcomes.
Women's health (London, England). 9(5):479-90 [DOI] 10.2217/whe.13.50. [PMID] 24007253.
2013
Coronary angiography: is it time to reassess?
Circulation. 127(17):1760-2 [DOI] 10.1161/CIRCULATIONAHA.113.002566. [PMID] 23630085.
2013
Detailed analysis of polymer response to delivery balloon expansion of drug-eluting stents versus bare metal stents.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9(3):389-97 [DOI] 10.4244/EIJV9I3A62. [PMID] 23872653.
2013
Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Hypertension (Dallas, Tex. : 1979). 62(4):746-52 [DOI] 10.1161/HYPERTENSIONAHA.113.01337. [PMID] 23959549.
2013
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials.
Clinical Medicine Insights. Cardiology. 7:1-20 [DOI] 10.4137/CMC.S10628. [PMID] 23400444.
2013
Electromechanical Assessment of Myocardial Function (Noga) Is Associated With Exercise Improvement in Patients Treated With Autologous Stem Cell Therapy for Refractory Angina
Journal of the American College of Cardiology. 61
2013
Electromechanical Assessment of Myocardial Function Is Associated With Improvement in Ejection Fraction in Patients Treated With Autologous Stem Cell Therapy for Ischemic Cardiomyopathy
Circulation. 128(22, S)
2013
Enhancing the function of CD34(+) cells by targeting plasminogen activator inhibitor-1.
PloS one. 8(11) [DOI] 10.1371/journal.pone.0079067. [PMID] 24223881.
2013
Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes.
Circulation. Cardiovascular genetics. 6(2):184-92 [DOI] 10.1161/CIRCGENETICS.111.964627. [PMID] 23392654.
2013
Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
Pharmacogenetics and genomics. 23(12):697-705 [DOI] 10.1097/FPC.0000000000000012. [PMID] 24128935.
2013
Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN.
Expert review of cardiovascular therapy. 11(11):1495-502 [DOI] 10.1586/14779072.2013.839943. [PMID] 24147517.
2013
Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Cardiovascular diagnosis and therapy. 3(4):216-27 [DOI] 10.3978/j.issn.2223-3652.2013.10.07. [PMID] 24400205.
2013
Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women’s Ischemia Syndrome Evaluation.
Journal of hypertension. 31(7):1447-54; discussion 1454 [DOI] 10.1097/HJH.0b013e3283611bac. [PMID] 23615325.
2013
Lack of association of the HMGA1 IVS5-13insC variant with type 2 diabetes in an ethnically diverse hypertensive case control cohort.
Journal of translational medicine. 11 [DOI] 10.1186/1479-5876-11-12. [PMID] 23302499.
2013
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study.
Cardiovascular diagnosis and therapy. 3(2):64-72 [PMID] 24015377.
2013
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
Human molecular genetics. 22(8):1663-78 [DOI] 10.1093/hmg/dds555. [PMID] 23303523.
2013
Mild Renal Insufficiency Predicts Mortality and Adverse Events in Women With Cardiac Ischemia, Independent of the Underlying Obstructive Coronary Artery Disease
Circulation. 128(22, S)
2013
Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
Clinical cardiology. 36(8):442-7 [DOI] 10.1002/clc.22145. [PMID] 23720247.
2013
Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
PloS one. 8(12) [DOI] 10.1371/journal.pone.0081595. [PMID] 24312563.
2013
Oxidative Stress Independently Predicts Diastolic Dysfunction in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: Results From the Nhlbi-Sponsored Women Ischemia Syndrome Evaluation (Wise)
Circulation. 128(22, S)
2013
Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes.
Hypertension (Dallas, Tex. : 1979). 62(1):48-54 [DOI] 10.1161/HYPERTENSIONAHA.111.00823. [PMID] 23690342.
2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).
Circulation. 127(15):1630-5 [DOI] 10.1161/CIRCULATIONAHA.112.000779. [PMID] 23588961.
2013
Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.
Journal of the American Heart Association. 2(4) [DOI] 10.1161/JAHA.113.000205. [PMID] 23948642.
2013
The Editor’s Roundtable: The 10Q Report – Advancing women’s heart health through improved research, diagnosis, and treatment.
The American journal of cardiology. 112(10):1676-87 [DOI] 10.1016/j.amjcard.2013.09.003. [PMID] 24157193.
2013
The Nhlbi Time Trial: One-Year Results
Circulation. 128(24)
2013
The serpin solution; targeting thrombotic and thrombolytic serine proteases in inflammation.
Cardiovascular & hematological disorders drug targets. 13(2):99-110 [PMID] 23987998.
2013
Variable and Decreased Clonogenic Activity of Autologous Bone Marrow in Cell Therapy Patients With Ischemic Heart Disease, and Cd34 as a Biomarker for Clinical Outcomes: Results From the Cardiovascular Cell Therapy Research Network (Cctrn)
Circulation. 128(22, S)
2012
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarction.
Medical hypotheses. 79(5):673-7 [DOI] 10.1016/j.mehy.2012.08.006. [PMID] 22939314.
2012
Alpha Adducin-1 (Add1)Singlenucleotide Polymorphism (Snp) Associated With New Onset Diabetes Risk With Hydrochlorothiazide (Hctz) Therapy in the International Verapamil Sr Trandolapril Genetic Substudy (Invest-Genes)
Clinical Pharmacology & Therapeutics. 91
2012
An Injectable Acellular Capillary Hydrogel Improves Left Ventricular Function After Myocardial Infarction
Journal of the American College of Cardiology. 59
2012
Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network.
JACC. Cardiovascular imaging. 5(5):559-65 [DOI] 10.1016/j.jcmg.2011.12.018. [PMID] 22595165.
2012
Changes to polymer surface of drug-eluting stents during balloon expansion.
JAMA. 307(20):2148-50 [DOI] 10.1001/jama.2012.4111. [PMID] 22618916.
2012
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.
PloS one. 7(3) [DOI] 10.1371/journal.pone.0031930. [PMID] 22403620.
2012
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute–sponsored Women’s Ischemia Syndrome Evaluation study.
Psychosomatic medicine. 74(3):263-70 [DOI] 10.1097/PSY.0b013e31824a58ff. [PMID] 22434916.
2012
Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
BMC medical research methodology. 12 [DOI] 10.1186/1471-2288-12-119. [PMID] 22866767.
2012
Damage To Polymer Surface and Detachment of Polymer Fragments During Delivery Balloon Expansion of Drug-Eluting Stents: A Previously Unrecognized Source for Adverse Outcomes
Journal of the American College of Cardiology. 59(13, S)
2012
Differential Effects of Cold Pressor and Acetylcholine During Endothelial Function Assessment in Women With No Obstructive Coronary Artery Disease: the Nhlbi-Sponsored Women’S Ischemia Syndrome Evaluation (Wise) Study
Journal of the American College of Cardiology. 59
2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA. 308(22):2380-9 [PMID] 23129008.
2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA. 307(16):1717-26 [DOI] 10.1001/jama.2012.418. [PMID] 22447880.
2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion. 52(10):2225-33 [DOI] 10.1111/j.1537-2995.2011.03543.x. [PMID] 22320233.
2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
Hypertension (Dallas, Tex. : 1979). 60(4):957-64 [DOI] 10.1161/HYPERTENSIONAHA.112.198721. [PMID] 22949529.
2012
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
American journal of human genetics. 90(3):410-25 [DOI] 10.1016/j.ajhg.2011.12.022. [PMID] 22325160.
2012
Mortality Associated With Angina and Blood Pressure Control Among Hypertensive Patients With Coronary Artery Disease: New Data From Extended Follow-Up of the International Verapamil/Trandolapril Study
Journal of the American College of Cardiology. 59
2012
Mortality Associated With Angina and Blood Pressure Control Among Hypertensive Patients With Coronary Artery Disease: New Data From Extended Follow-Up of the International Verapamil/Trandolapril Study
Journal of the American College of Cardiology. 59
2012
Non-Synonymous Snps in Sele, Selp, and Siglec12 Associate With Cardiovascular (Cv) Outcomes in the International Verapamil Sr-Trandol-April Study Genetic Substudy (Invest-Genes)
Clinical Pharmacology & Therapeutics. 91:S20-S21
2012
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women.
Journal of women's health (2002). 21(2):133-9 [DOI] 10.1089/jwh.2011.2787. [PMID] 21988550.
2012
Relationships Between Components of Metabolic Syndrome and Coronary Intravascular Ultrasound (Ivus) Atherosclerosis Measures in Women Without Obstructive Coronary Artery Disease: the Nhlbi-Sponsored Women’S Ischemia Syndrome Evaluation (Wise) Study
Journal of the American College of Cardiology. 59(13, S)
2012
Rethinking stable ischemic heart disease: is this the beginning of a new era?
Journal of the American College of Cardiology. 60(11):957-9 [DOI] 10.1016/j.jacc.2012.04.046. [PMID] 22954240.
2012
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study.
JACC. Cardiovascular interventions. 5(6):646-53 [DOI] 10.1016/j.jcin.2012.01.023. [PMID] 22721660.
2012
Simple Prediction of Long-Term Mortality Among Hypertensive Patients With Coronary Artery Disease: New Data From An Extended Follow-Up of the International Verapamil-Sr/Trandolapril Study (Invest)
Journal of the American College of Cardiology. 59
2012
Treatment of hypertension: lower is better, or is it?
Hypertension (Dallas, Tex. : 1979). 60(2):281-2 [DOI] 10.1161/HYPERTENSIONAHA.112.197632. [PMID] 22753207.
2012
Treatment-Resistant Blood Pressure Among Patients With Coronary Artery Disease – Cause for Concern: New Data From the Extended Follow-Up of the International Verapamail Sr-Trandolapril Study (Invest)
Journal of the American College of Cardiology. 59
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
Journal of the American College of Cardiology. 57(20):2037-114 [DOI] 10.1016/j.jacc.2011.01.008. [PMID] 21524875.
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
Journal of the American Society of Hypertension : JASH. 5(4):259-352 [DOI] 10.1016/j.jash.2011.06.001. [PMID] 21771565.
2011
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
Circulation. 123(21):2434-506 [DOI] 10.1161/CIR.0b013e31821daaf6. [PMID] 21518977.
2011
Blood pressure lowering in patients with diabetes–one level might not fit all.
Nature reviews. Cardiology. 8(1):42-9 [DOI] 10.1038/nrcardio.2010.182. [PMID] 21079637.
2011
Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
Circulation. Cardiovascular genetics. 4(2):169-78 [DOI] 10.1161/CIRCGENETICS.110.959296. [PMID] 21372283.
2011
Could Retinal Imaging Provide a Simple, Inexpensive, Noninvasive Index for Coronary Microvascular Function in Women With Chest Pain and Nonobstructive Coronary Artery Disease? An Ancillary Pilot Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise-Aric)
Journal of the American College of Cardiology. 57
2011
Could Retinal Imaging Provide a Simple, Inexpensive, Noninvasive Index for Coronary Microvascular Function in Women With Chest Pain and Nonobstructive Coronary Artery Disease? An Ancillary Pilot Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise-Aric)
Journal of the American College of Cardiology. 57
2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale.
American heart journal. 162(6):973-80 [DOI] 10.1016/j.ahj.2011.05.024. [PMID] 22137069.
2011
Does Angiotensin Plus Aldosterone Inhibition Improve Coronary Endothelial Function? An Ancillary Study From the Nhlbi-Sponsored Women’s Ischemia Syndrome Evaluation (Wise)
Journal of the American College of Cardiology. 57
2011
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA. 306(19):2110-9 [DOI] 10.1001/jama.2011.1670. [PMID] 22084195.
2011
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women’s Ischemia Syndrome Evaluation (WISE) ancillary study.
Clinical cardiology. 34(8):483-7 [DOI] 10.1002/clc.20935. [PMID] 21780138.
2011
Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
The American journal of cardiology. 107(6):898-905 [DOI] 10.1016/j.amjcard.2010.11.009. [PMID] 21247520.
2011
Genetic Variation in the Calcium Signaling Pathway and Association With Outcomes in Hypertensive Coronary Artery Disease Patients
Clinical Pharmacology & Therapeutics. 89
2011
Genetic Variation in the Calcium Signaling Pathway and Association With Outcomes in Hypertensive Coronary Artery Disease Patients
Clinical Pharmacology & Therapeutics. 89
2011
Harmful effects of NSAIDs among patients with hypertension and coronary artery disease.
The American journal of medicine. 124(7):614-20 [DOI] 10.1016/j.amjmed.2011.02.025. [PMID] 21596367.
2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 162(4):678-84 [DOI] 10.1016/j.ahj.2011.07.011. [PMID] 21982660.
2011
Intramyocardial, autologous CD34+ cell therapy for refractory angina.
Circulation research. 109(4):428-36 [DOI] 10.1161/CIRCRESAHA.111.245993. [PMID] 21737787.
2011
Kcnj1 Snps Are Associated With Increased Fasting Glucose and Risk of New Onset Diabetes During Hctz Therapy
Clinical Pharmacology & Therapeutics. 89
2011
Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
Pharmacogenetics and genomics. 21(6):333-40 [DOI] 10.1097/FPC.0b013e3283452fec. [PMID] 21562465.
2011
Microvascular dysfunction: What have we learned from WISE?
Expert review of cardiovascular therapy. 9(12):1491-4 [DOI] 10.1586/erc.11.165. [PMID] 22103866.
2011
Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
Pharmacogenetics and genomics. 21(1):42-9 [DOI] 10.1097/FPC.0b013e328341e911. [PMID] 21127457.
2011
Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network.
JACC. Cardiovascular imaging. 4(6):671-9 [DOI] 10.1016/j.jcmg.2011.02.015. [PMID] 21679903.
2011
Relationship Between Coronary Micro- and Macrovascular Measures in Women With Chest Pain Without Significant Coronary Artery Disease: An Ancillary Substudy From the Nhbli-Sponsored Women’s Ischemia Syndrome Evaluation (Wise)
Journal of the American College of Cardiology. 57
2011
Response To Letter Regarding Article “Chromosome 9P21 Haplotypes and Prognosis in White and Black Patients With Coronary Artery Disease”
Circulation-Cardiovascular Genetics. 4(4) [DOI] 10.1161/CIRCGENETICS.111.960807.
2011
Results From Latetime: a Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two To Three Weeks Following Acute Myocardial Infarction
Circulation. 124
2011
Syndrome X and microvascular coronary dysfunction.
Circulation. 124(13):1477-80 [DOI] 10.1161/CIRCULATIONAHA.110.974212. [PMID] 21947935.
2011
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation.
Menopause (New York, N.Y.). 18(9):943-50 [DOI] 10.1097/gme.0b013e3182113672. [PMID] 21532511.
2011
What causes myocardial infarction in women without obstructive coronary artery disease?
Circulation. 124(13):1404-6 [DOI] 10.1161/CIRCULATIONAHA.111.055855. [PMID] 21947933.
2010
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
American heart journal. 159(6):987.e1-7 [DOI] 10.1016/j.ahj.2010.03.024. [PMID] 20569710.
2010
A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Circulation. Cardiovascular interventions. 3(6):543-8 [DOI] 10.1161/CIRCINTERVENTIONS.110.953885. [PMID] 21062996.
2010
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE).
Journal of interventional cardiology. 23(6):511-9 [DOI] 10.1111/j.1540-8183.2010.00598.x. [PMID] 21029178.
2010
Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner.
PloS one. 5(12) [DOI] 10.1371/journal.pone.0015180. [PMID] 21170323.
2010
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.
The American journal of medicine. 123(8):719-26 [DOI] 10.1016/j.amjmed.2010.02.014. [PMID] 20670726.
2010
Bone marrow-derived cells and hypertension.
Expert review of cardiovascular therapy. 8(8):1139-48 [DOI] 10.1586/erc.10.105. [PMID] 20670191.
2010
Clinical Association of Variation in the Beta 2 Regulatory Subunit of the Voltage- Gated Calcium Channel ( Cacnb2) With Outcomes in Hypertensive Coronary Artery Disease ( Cad) Patients.
Clinical Pharmacology & Therapeutics. 87
2010
Clinical Association of Variation in the Beta 2 Regulatory Subunit of the Voltage- Gated Calcium Channel (Cacnb2) With Outcomes in Hypertensive Coronary Artery Disease (Cad) Patients.
Clinical Pharmacology & Therapeutics. 87
2010
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Clinical cardiology. 33(10):609-619 [DOI] 10.1002/clc.20830. [PMID] 20960535.
2010
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women’s Ischemia Syndrome Evaluation) study.
Journal of the American College of Cardiology. 55(25):2825-32 [DOI] 10.1016/j.jacc.2010.01.054. [PMID] 20579539.
2010
Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]).
The American journal of cardiology. 106(4):498-503 [DOI] 10.1016/j.amjcard.2010.03.056. [PMID] 20691307.
2010
Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN).
Journal of cardiovascular translational research. 3(1):30-6 [DOI] 10.1007/s12265-009-9160-3. [PMID] 20445812.
2010
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health–National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE).
The Journal of clinical endocrinology and metabolism. 95(11):4985-92 [DOI] 10.1210/jc.2010-0143. [PMID] 20739385.
2010
Endothelium as a predictor of adverse outcomes.
Clinical cardiology. 33(12):730-2 [DOI] 10.1002/clc.20854. [PMID] 21184555.
2010
Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
Circulation. Cardiovascular genetics. 3(6):548-55 [DOI] 10.1161/CIRCGENETICS.110.957654. [PMID] 21156931.
2010
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.
Circulation. 121(12):1447-54 [DOI] 10.1161/CIRCULATIONAHA.109.904029. [PMID] 20351302.
2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
American heart journal. 160(2):215-23 [DOI] 10.1016/j.ahj.2010.03.029. [PMID] 20691824.
2010
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Texas Heart Institute journal. 37(4):412-20 [PMID] 20844613.
2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.
Cytotherapy. 12(5):684-91 [DOI] 10.3109/14653249.2010.487900. [PMID] 20524773.
2010
New-Onset Diabetes Risk Associated With Antihypertensive Therapy in Hypertensive Coronary Artery Disease Patients Is Modified By a Single Nucleotide Polymorphism (Snp) in the L-Type Calcium Channel (Ltcc)
Clinical Pharmacology & Therapeutics. 87
2010
Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.
Hypertension (Dallas, Tex. : 1979). 55(1):48-53 [DOI] 10.1161/HYPERTENSIONAHA.109.142240. [PMID] 19996066.
2010
Pathophysiologic mechanisms linking impaired cardiovascular health and neurologic dysfunction: the year in review.
Cleveland Clinic journal of medicine. 77 Suppl 3:S40-5 [DOI] 10.3949/ccjm.77.s3.07. [PMID] 20622075.
2010
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.
European heart journal. 31(8):958-66 [DOI] 10.1093/eurheartj/ehp548. [PMID] 20034973.
2010
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women’s Ischemia Syndrome Evaluation) study.
JACC. Cardiovascular imaging. 3(10):1030-6 [DOI] 10.1016/j.jcmg.2010.07.008. [PMID] 20947048.
2010
Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
Annals of medicine. 42(1):19-35 [DOI] 10.3109/07853890903260898. [PMID] 20092398.
2010
Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation.
Psychosomatic medicine. 72(6):549-55 [DOI] 10.1097/PSY.0b013e3181dc0259. [PMID] 20410246.
2010
The use of diuretics plus calcium channel blockers for hypertension may be associated with a higher risk of myocardial infarction but not stroke compared with the combination of diuretics plus beta blockers.
Evidence-based medicine. 15(3):92-3 [DOI] 10.1136/ebm1067. [PMID] 20522694.
2010
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
JAMA. 304(1):61-8 [DOI] 10.1001/jama.2010.884. [PMID] 20606150.